Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

FDA Approves Aficamten for Obstructive HCM

News Daily News

FDA Approves Aficamten for Obstructive HCM

December 29, 2025

AHA Statement Zeroes In On Sleep Health

News Daily News

AHA Statement Zeroes In On Sleep Health

April 17, 2025

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

April 15, 2025

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

October 02, 2024

July 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

July 01, 2024

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

October 07, 2022

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

News Daily News

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

February 10, 2022

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

February 06, 2014

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

October 23, 2012

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

October 23, 2012

News Daily News

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

May 27, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.